Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial

作者：Ashkan Shoamanesh, Thalia S. Field, Shelagh B. Coutts, Mukul Sharma, David J. Gladstone, Robert G. Hart, Giuseppe Boriani, David J. Wright, Christian Sticherling, David H. Birnie, Michael R. Gold, Julia W. Erath, Valentina Kutyifa, Rajibul Mian, Alexander P. Benz, Christopher B. Granger, William F McIntyre, Stuart J. Connolly, Jens Cosedis Nielsen, Marco Alings, Léna Rivard, Renato D Lopes, Jeff S. Healey · 发表于：The Lancet Neurology · 年份：2025 · DOI：10.1016/s1474-4422(24)00475-7 · 被引用次数：50 · 研究领域：Atrial Fibrillation Management and Outcomes、Intracerebral and Subarachnoid Hemorrhage Research、Acute Ischemic Stroke Management